Abstract
Regadenoson is a selective adenosine A2a receptor agonist, now being used extensively for radionuclide myocardial perfusion imaging (MPI). Patients with reactive airway disease are at an increased risk for adenosine induced bronchoconstriction via stimulation of A2b and A3 receptors. All patients
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have